Infection News

A hard stop clinical decision support tool embedded in the electronic medical record significantly reduced repeat Clostridioides difficile toxin enzyme immunoassay, or T-EIA, testing at a hospital in St. Louis.

Albumin levels and liver stiffness measurements taken during direct-acting antiviral therapy follow-up can stratify liver cancer risk among patients with hepatitis C and compensated advanced chronic liver disease, according to study results.

In this guest commentary, Jessica Allegretti , MD, MPH, of the Brigham and Women’s Hospital Crohn’s and Colitis Center, discusses the recent FDA hearing on the agency’s policy of enforcement discretion of fecal microbiota transplantation for recurrent Clostridioides difficile infection.

Researchers discovered potential for a simplified monitoring schedule compared with standard monitoring among certain patients treated direct-acting antivirals for chronic hepatitis C, according to data published in Journal of Hepatology.

The FDA approved Talicia for the treatment of Helicobacter pylori infection in adults, manufacturer Redhill Biopharma announced.

The FDA held a public comment session on Monday in Washington, D.C., to hear testimony on the agency’s policy on enforcement discretion of fecal microbiota transplantation for patients with recurrent Clostridioides difficile infection, as well as what is needed to make a path forward toward approval.

SAN ANTONIO — In this exclusive video from the American College of Gastroenterology Annual Meeting, Mark S. Riddle, MD, of the University of Nevada Reno School of Medicine, discusses his presentation on the effects of single-dose antibiotics on the microbiome in traveler’s diarrhea.

In June, the FDA issued a safety alert after two patients who had received investigational fecal microbiota transplants in two separate clinical trials developed invasive infections caused by drug-resistant Escherichia coli, and one died.

SAN ANTONIO — In this exclusive video from the National Liver Conference 2019, Robert Gish, MD, an adjunct professor at the University of Nevada Reno School of Medicine, provides an overview of a presentation on hepatitis B that focused on which patients benefit the most from treatment.

SAN ANTONIO — New, single use duodenoscopes received overall good marks for use in endoscopic retrograde cholangiopancreatography from a group of expert endoscopists, according to study results presented at the American College of Gastroenterology Annual Meeting.